Targeting severe symptoms of early 2023-new outbreak of COVID-19 by classical drug dexamethasone: a potential fatality reducing agent

Detalles Bibliográficos
Autores principales: Liu, Dongsheng, Saeed, Aamir, Majaz, Sidra, Ahmad, Bashrat, Ahmad, Ashfaq, Xie, Yingqiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213593/
https://www.ncbi.nlm.nih.gov/pubmed/37237409
http://dx.doi.org/10.1186/s12967-023-04186-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213593/
https://www.ncbi.nlm.nih.gov/pubmed/37237409
http://dx.doi.org/10.1186/s12967-023-04186-4

Ejemplares similares